Form 8-K - Current report:
SEC Accession No. 0001193125-25-109946
Filing Date
2025-05-01
Accepted
2025-05-01 16:05:31
Documents
15
Period of Report
2025-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d919727d8k.htm   iXBRL 8-K 25121
2 EX-99.1 d919727dex991.htm EX-99.1 41280
6 GRAPHIC g919727snap1.jpg GRAPHIC 6155
  Complete submission text file 0001193125-25-109946.txt   205059

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA etnb-20250501.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20250501_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20250501_pre.xml EX-101.PRE 11257
17 EXTRACTED XBRL INSTANCE DOCUMENT d919727d8k_htm.xml XML 3634
Mailing Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 25902996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)